Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin vs Hesperidin/Diosmin in Fibromyalgia
NCT07293767Recruiting
- Sponsor
- Ain Shams University
- Start
- Nov 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of silymarin and micronized purified flavonoid fraction in fibromyalgia (FM) (3 arms), sponsored by Ain Shams University. Primary endpoint: Fibromyalgia Impact Questionnaire at 4 months. Started Nov 2024; status: recruiting.
02
Drugs
silymarinmicronized purified flavonoid fraction
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07293767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07293767.